Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2001
05/03/2001WO2001030845A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto
05/03/2001WO2001030844A1 Dna encoding human alpha1g-c t-type calcium channel
05/03/2001WO2001030843A1 Ligand activated transcriptional regulator proteins
05/03/2001WO2001030842A1 A new polypeptide-zinc finger protein 36 and the polynucleotide encoding it
05/03/2001WO2001030841A1 A new polypeptide-zinc finger protein 60 and the polynucleotide encoding it
05/03/2001WO2001030840A1 A new polypeptide-zinc finger protein 57 and the polynucleotide encoding it
05/03/2001WO2001030839A1 A novel polypeptide-human rna-binding protein 33 and a polynucleotide encoding the same
05/03/2001WO2001030838A1 A novel polypeptide - gtp-binding protein 17 and a polynucleotide encoding the same
05/03/2001WO2001030837A1 A novel polypeptide - human galectin 15 and a polynucleotide encoding the same
05/03/2001WO2001030834A1 A new polypeptide-zinc finger protein 33 and the polynucleotide encoding it
05/03/2001WO2001030833A1 A new polypeptide - new cell cycle-regulating protein 53 and a polynucleotide encoding the same
05/03/2001WO2001030832A1 A new polypeptide-zinc finger protein hkznf-23 and the polynucleotide encoding it
05/03/2001WO2001030831A1 Secreted proteins and uses thereof
05/03/2001WO2001030830A2 Gene sequences identified by protein motif database searching
05/03/2001WO2001030829A1 A novel human metabotropic glutamate receptor
05/03/2001WO2001030828A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2)
05/03/2001WO2001030827A1 A novel polypeptide-zinc finger protein 56 and polynucleotide encoding said polypeptide
05/03/2001WO2001030825A1 A novel polypeptide-human splicing factor 25 and the polynucleotide encoding said polypeptide
05/03/2001WO2001030823A1 A novel polypeptide-human circular canal protein 69 and the polynucleotide encoding said polypeptide
05/03/2001WO2001030820A1 A novel polypeptide-zinc finger protein 54 and polynucleotide encoding said polypeptide
05/03/2001WO2001030819A1 A novel polypeptide-human tropomodulin 39 and the polynucleotide encoding said polypeptide
05/03/2001WO2001030818A1 A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide
05/03/2001WO2001030817A1 Immunogenic proteins from the domestic mite, blomia tropicalis
05/03/2001WO2001030816A1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE
05/03/2001WO2001030815A1 Redox reversible hcv proteins with native-like conformation
05/03/2001WO2001030814A1 Deglycosylated env/cd4 complex and the use thereof for vaccination against hiv
05/03/2001WO2001030813A1 Novel molecules of the card-related protein family and uses thereof
05/03/2001WO2001030812A2 Activation of hcv-specific t cells
05/03/2001WO2001030811A2 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis
05/03/2001WO2001030810A2 Relaxase and other vir proteins as targets for treatment of helicobacter pylori infection and as dna transfer system to mammalian cells
05/03/2001WO2001030808A1 Methods and compounds for modulating melanocortin receptor-ligand binding
05/03/2001WO2001030806A1 Polynucleotides and polypeptides involved in biofilm biology and their uses
05/03/2001WO2001030805A1 Silicone liquids as temperature regulating media for processes involving microwave facilitated transformations
05/03/2001WO2001030798A1 Transgenic mice containing trp gene disruptions
05/03/2001WO2001030394A1 Treatment of cancer
05/03/2001WO2001030392A2 Delivery of proteins across polar epithelial cell layers
05/03/2001WO2001030384A1 Vaccine compositions
05/03/2001WO2001030382A1 Method of inducing and/or enhancing an immune response to tumor antigens
05/03/2001WO2001030377A1 Porcine b7-1 and antibodies thereto
05/03/2001WO2001030376A2 Use of urodilatin for treating chronic kidney failure with residual kidney functions
05/03/2001WO2001030374A1 Stem cell engraftment-enhancing cellular proteins and their uses
05/03/2001WO2001030368A1 Method for pr-39 peptide regulated stimulation of angiogenesis
05/03/2001WO2001030354A1 REGULATION OF Apob FOR DIAGNOSIS, TREATMENT AND DRUG SCREENING FOR CARDIOVASCULAR AND METABOLIC DISORDERS OR SYNDROMES
05/03/2001WO2001030300A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
05/03/2001WO2001030137A1 N-calcium channel knockout animal
05/03/2001WO2001016596A3 Screening for modulators of gaba b receptor activity
05/03/2001WO2001010897A3 Methods and compositions for detecting larval taenia solium
05/03/2001WO2001005968A9 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor
05/03/2001WO2001005812A3 PEPTIDES AND THEIR UTILITY IN MODULATION OF BEHAVIOR OF CELLS EXPRESSING α3β1 INTEGRINS
05/03/2001WO2001002370B1 Nickel-based reagents for detecting dna and dna-protein contacts
05/03/2001WO2001001144A3 Hybridization of target dna with immobilized nucleic acid analogs
05/03/2001WO2001000666A3 Self-aligning peptides derived from human elastin and other fibrous proteins
05/03/2001WO2001000664A3 Secreted alpha-helical protein-36
05/03/2001WO2001000221A3 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
05/03/2001WO2000078957A3 Scorpion toxins from buthotus judaicus
05/03/2001WO2000078802A3 Secreted polypeptides and corresponding polynucleotides
05/03/2001WO2000077214A3 Characterization of the yeast transcriptome
05/03/2001WO2000075332A3 USE OF THE REGULATORY SUBUNIT OF THE CAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS
05/03/2001WO2000075320A3 Human genes and proteins encoded thereby
05/03/2001WO2000073431A3 Methods and compositions for measuring ion channel conductance
05/03/2001WO2000068390A3 Plant recombination proteins
05/03/2001WO2000068263A3 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
05/03/2001WO2000065028A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
05/03/2001WO2000063245A3 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
05/03/2001WO2000054813A3 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
05/03/2001DE19952160A1 Verfahren, Vorrichtung und farbstoffmarkiertes Peptid zum Nachweis eines Moleküls, sowie Verfahren zur Herstellung eines farbstoffmarkierten Peptids und dessen Verwendung A method, apparatus and dye-labeled peptide for the detection of a molecule, and to methods for preparing a dye-labeled peptide and use thereof
05/03/2001DE19951824A1 New N-terminal fragment of insulin-like growth factor binding protein-3 and its complexes with growth factors for treatment and diagnosis of e.g. muscular atrophy
05/03/2001DE19951708A1 Für den Export verzweigtkettiger Aminosäuren kodierende Nikleotidsequenzen, Verfahren zu deren Isolierung und ihre Verwendung Coding for the Export of branched-chain amino acids Nikleotidsequenzen, processes for their isolation and their use
05/03/2001DE19951471A1 Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen Use of Urodilatin for the treatment of chronic renal insufficiency with residual renal function
05/03/2001DE19949595A1 CTAGE-Genfamilie CTAGE gene family
05/03/2001DE19949436A1 New human antibiotic peptides, useful for treating microbial infections, particularly when incorporated in wound dressings, also related nucleic acid
05/03/2001DE19949179A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid
05/03/2001CA2721011A1 Modified gp100 and uses thereof
05/03/2001CA2404438A1 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases
05/03/2001CA2391820A1 Umlr polypeptides
05/03/2001CA2389834A1 Genetic sequences associated with neural cell proliferation and disease
05/03/2001CA2389522A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response
05/03/2001CA2389321A1 Neisserial antigenic peptides
05/03/2001CA2389256A1 Beta-defensins
05/03/2001CA2389217A1 Mammalian-type glycosylation in plants
05/03/2001CA2389113A1 Plants with a modified flower and seed development
05/03/2001CA2389110A1 Regulation of gene expression by neuroleptic agents
05/03/2001CA2389031A1 Dna encoding human alpha1g-c t-type calcium channel
05/03/2001CA2388998A1 Treatment of cancer
05/03/2001CA2388950A1 Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application
05/03/2001CA2388942A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2)
05/03/2001CA2388868A1 Method for pr-39 peptide regulated stimulation of angiogenesis
05/03/2001CA2388642A1 A method and computer system to design primers utilizing a first and second target nucleotide sequence
05/03/2001CA2388637A1 Human fgf-20 gene and gene expression products
05/03/2001CA2388617A1 Nucleic acid molecules derived from rat brain and programmed cell death models
05/03/2001CA2388599A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same
05/03/2001CA2388535A1 Ligand activated transcriptional regulator proteins
05/03/2001CA2388514A1 A novel human metabotropic glutamate receptor
05/03/2001CA2388338A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
05/03/2001CA2388337A1 Method of inducing and/or enhancing an immune response to tumor antigens
05/03/2001CA2388165A1 Disulfide conjugated cell toxins and methods of making and using them
05/03/2001CA2388162A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana
05/03/2001CA2388130A1 Molecularly imprinted polymers produced by template polymerisation
05/03/2001CA2387907A1 Serum amyloid a isoform from colostrum
05/03/2001CA2387897A1 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis